Vira-A (Vidarabine) Patient Information: Missed a Dose and What Should I Avoid at RxList

Pill Identifier Search

May 27, 2012

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Vira-A

Adult Skin Problems Slideshow Pictures

How Smoking Affects Your Looks Slideshow Pictures

Weight Gain Shockers Slideshow

font size

Please Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Vira-A Patient Information including If I Miss a Dose

What happens if I miss a dose (Vira-A)?

Apply the missed dose as soon as you remember. However, if it is almost time for the next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.

What happens if I overdose (Vira-A)?

An overdose of this medication is not expected to cause harm.

If an overdose occurs in the eye, flush the eye with water for several minutes. If the ointment is ingested, drink plenty of fluid to dilute the medicine. The ingestion of a whole tube of vidarabine ophthalmic is not expected to cause harm. Call an emergency room or poison control center for additional advice in either of these situations.

What should I avoid while using vidarabine ophthalmic (Vira-A)?

Do not touch the tube opening to any surface, including the eyes or hands. The tube opening is sterile. If it becomes contaminated, it could cause an infection in the eye.

Vidarabine ophthalmic may increase the sensitivity of the eyes to bright light. Wear sunglasses to prevent irritation.

Use caution when driving, operating machinery, or performing other hazardous activities. Vidarabine ophthalmic may cause blurred vision. If you experience blurred vision, avoid these activities.

Discuss with your doctor the use of contact lenses. After applying this medication, wait at least 15 minutes before inserting contact lenses.

Avoid other eye medications except under the direction of your doctor.

What other drugs will affect vidarabine ophthalmic (Vira-A)?

Avoid other eye medications except under the direction of your doctor.

Drugs other than those listed here may also interact with vidarabine ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including herbal products.

Where can I get more information?

Your pharmacist has additional information about vidarabine ophthalmic written for health professionals that you may read.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2009 Cerner Multum, Inc. Version: 3.03. Revision date: 2/13/04.

Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.